Home β€Ί Stock analysis β€Ί OGI

Organigram Global (OGI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

OGI dips 0.6% to $0.93. Closed at $0.93, -0.57% vs the prior close of $0.93. Day range $0.92–$0.94, opened at $0.92.

Last close$0.93-0.57%
Day range0.92–0.94
Open0.92
Volume248.43K
52-week range0.85–2.24
Avg volume (20d)484.16K

OGI daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” OGI dips 0.6% to $0.93
Oct 15, 2026 β€” OGI jumps 3.1% to $0.93
Oct 14, 2026 β€” OGI dips 1.6% to $0.90, a 1-month low, 3 down days in a row
Oct 13, 2026 β€” OGI dips 1.7% to $0.92, a 1-month low
Oct 12, 2026 β€” OGI dips 2.5% to $0.94, a 1-month low
Oct 9, 2026 β€” OGI rises 0.8% to $0.96
Oct 8, 2026 β€” OGI dips 0.9% to $0.95
Oct 7, 2026 β€” OGI dips 1.0% to $0.96
Oct 6, 2026 β€” OGI jumps 3.5% to $0.97
Oct 5, 2026 β€” OGI dips 1.7% to $0.94, a 1-month low, 7 down days in a row
Oct 2, 2026 β€” OGI dips 3.0% to $0.95, a 1-month low, 6 down days in a row

OGI latest news & SEC filings

Every SEC filing by or about OGI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 15, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-065965

Sep 30, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-063957

Sep 3, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-060243

Sep 1, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001062993-26-004753

Aug 20, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-058209

Aug 11, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-055496

Aug 4, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-052218

Jul 20, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-048830

Things to know before you trade OGI

OGI market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20260.920.940.920.93248.43K
Oct 15, 20260.900.940.890.93279.30K
Oct 14, 20260.910.920.890.90396.20K
Oct 13, 20260.930.940.900.92361.50K
Oct 12, 20260.950.960.930.94248.30K
Oct 9, 20260.940.960.930.96292.60K
Oct 8, 20260.970.970.930.95369.90K
Oct 7, 20260.970.980.960.96293.70K
Oct 6, 20260.940.990.930.97417.90K
Oct 5, 20260.950.960.920.94674.30K
Oct 2, 20260.980.990.950.95726.10K
Oct 1, 20261.001.020.980.98518.90K
Sep 30, 20261.051.050.991.00943.30K
Sep 29, 20261.081.101.021.07834.20K
Sep 28, 20261.101.111.071.09534.10K
Sep 25, 20261.101.111.091.10246.60K
Sep 24, 20261.081.101.071.10236.50K
Sep 23, 20261.121.121.081.09505.90K
Sep 22, 20261.101.131.101.11757.40K
Sep 21, 20261.041.131.041.12798.00K

About Organigram Global

Organigram Global (OGI) is listed on the Nasdaq and classified by the SEC under β€œPharmaceutical Preparations”. Its business address is in TORONTO. State of incorporation: Canada (Federal Level). Fiscal year ends September 30. SEC CIK 1620737.

OGI board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

OGI financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

OGI earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on OGI

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.